SLI
1.992,34
PKT
+3,74
PKT
+0,19
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
31.01.05 | Swatch (I) Buy | Sarasin Research | |
28.01.05 | Holcim Verkaufen | Helaba Trust | |
31.01.05 | Novartis Buy | Helvea | |
27.01.05 | Lonza Buy | Helvea | |
28.01.05 | Swatch (I) Neutral | JP Morgan | |
27.01.05 | Holcim Neutral | Helvea | |
03.02.05 | Novartis Outperformer | Sparkasse KölnBonn | |
27.01.05 | Adecco SA Accumulate | Helvea | |
27.01.05 | Holcim Halten | Helaba Trust | |
26.01.05 | Novartis Market Perform | William Blair | |
26.01.05 | Lindt In-Line | Goldman Sachs | |
26.01.05 | UBS Buy | Sarasin Research | |
26.01.05 | Lonza Reduce | Sarasin Research | |
26.01.05 | Lindt Neutral | Sarasin Research | |
26.01.05 | Nestlé Outperform | Credit Suisse First Boston | |
25.01.05 | Novartis Halten | LB Baden-Württemberg | |
25.01.05 | Lonza Overweight | JP Morgan | |
25.01.05 | Lindt Neutral | Helvea | |
25.01.05 | Novartis Outperform | Goldman Sachs | |
25.01.05 | Adecco SA Accumulate | Helvea | |
25.01.05 | Holcim Accumulate | Helvea | |
25.01.05 | UBS Buy | Helvea | |
25.01.05 | Novartis Buy | Helvea | |
25.01.05 | Swisscom Underweight | Lehman Brothers | |
24.01.05 | Novartis Overweight | Prudential Securities | |
24.01.05 | Richemont Neutral | Merrill Lynch | |
24.01.05 | Holcim Neutral | Sarasin Research | |
25.01.05 | Novartis Neutral | Sarasin Research | |
24.01.05 | Richemont Outperform | Goldman Sachs | |
24.01.05 | Novartis Neutral | Sarasin Research | |
21.01.05 | Roche Buy | Sarasin Research | |
24.01.05 | Lonza Reduce | Sarasin Research | |
21.01.05 | Zurich Insurance Buy | Sarasin Research | |
21.01.05 | Novartis Kaufen | Helaba Trust | |
24.01.05 | Straumann Outperform | Credit Suisse First Boston | |
21.01.05 | Holcim Accumulate | Helvea | |
21.01.05 | Richemont Accumulate | Helvea | |
21.01.05 | Zurich Insurance Accumulate | Helvea | |
24.01.05 | Novartis Kaufen | Hamburger Sparkasse | |
21.01.05 | Richemont Buy | Sarasin Research |